Citrullinated antibodies in systemic lupus erythematosus and primary Sjogren's syndrome

被引：0

作者：

Hullo, D. ^{[1
]}

Szoeke, L. ^{[2
]}

Szollosl, I ^{[3
]}

Balog, A. ^{[1
]}

Sonkodi, G. ^{[1
]}

Lele, K. ^{[1
]}

Torok, E. ^{[3
]}

Kovacs, L. ^{[1
]}

Zeher, M. ^{[3
]}

Sipka, S. ^{[3
]}

Pokorny, G. ^{[1
]}

机构：

[1] Univ Szeged, Dept Rheumatol, Szeged, Hungary

[2] Univ Szeged, Dept Clin Chem, Szeged, Hungary

[3] Univ Debrecen, Dept Internal Med 3, Debrecen, Hungary

来源：

2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI) | 2009年

关键词：

EROSIVE ARTHRITIS; REVISED CRITERIA; PEPTIDE; CLASSIFICATION;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Although anti-cyclic-citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) antibodies are highly sensitive scrological markers for the diagnosis of rheumatoid arthritis (RA). These antibodies can also occur in systemic lupus erythematosus (SLF) and in primary Sjogren's syndrome (SS). Of our 115 SLF patients. 21 (18.3%) were anti-MCV and 10(8.7%) anti-CCP positive. Of the 68 SS patients. 10 (14.7%) were anti-MCV and 7 (10.3%) anti-CCP positive. No correlation was observed between the antibody positivity and the organ manifestations. In the 139 RA control patients. anti-CCP positivity was more common (108/139) than anti-MCV positivity (92/139).

引用

页码：309 / +

页数：3

共 50 条

[41] Predicting Sjogren's Syndrome At Diagnosis of Systemic Lupus Erythematosus.
Hernandez-Molina, Gabriela
Zamora-Legoff, Tatiana
Romero-Diaz, Juanita
Alberto Nunez-Alvarez, Carlos
Cardenas-Velazquez, Francisco
Hernandez-Hernandez, Carlos
Luisa Calderillo, Maria
Marroquin, Martha
Recillas-Gispert, Claudia
Avila-Casado, Carmen
Sanchez-Guerrero, Jorge
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S950 - S951
[42] Autoimmune thyroid disease in systemic lupus erythematosus and Sjogren's syndrome
Scofield, RH
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (03) : 321 - 330
[43] PREVALENCE OF PRIMARY SJOGREN'S SYNDROME IN BYELORUSSIAN POPULATION AND SECONDARY SJOGREN'S SYNDROME FREQUENCY IN RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS PATIENTS
Dostanko, N.
Yagur, V.
Chizh, K.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 984 - 984
[44] COMPLEX IMMUNOPHENOTYPING STRATIFIES PATIENTS WITH PRIMARY SJOGREN'S SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY SJOGREN'S SYNDROME ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS INTO DISTINCT CLINICALLY RELEVANT GROUPS WITH POTENTIAL THERAPEUTIC IMPLICATIONS
Thompson, N.
Gandhi, A.
Radmmore, R.
Gupta, V.
Robinson, G.
Martin-Gutierrez, L.
Isenberg, D.
Jury, E.
Ciurtin, C.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 239 - 240
[45] Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome
Fujisawa, Tomomi
Seishima, Mariko
Suzuki, Satoko
Shibuya, Yoshinao
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB64 - AB64
[46] Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome
Fujisawa, Tomomi
Seishima, Mariko
MODERN RHEUMATOLOGY, 2010, 20 (04) : 396 - 400
[47] SPONTANEOUS SPLENIC HYPOFUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND PRIMARY SJOGREN SYNDROME
VALLES, R
RIVERO, I
MORAN, D
DIUMENJO, MS
MEDICINA-BUENOS AIRES, 1993, 53 (05) : 397 - 400
[48] Lupus miliaris disseminatum faciei in a patient with systemic lupus erythematosus and Sjogren's syndrome
Watanabe, Yukina
Saitou, Marumi
Yamamoto, Toshiyuki
JOURNAL OF DERMATOLOGY, 2021, 48 (01): : 110 - 113
[49] Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome
Nezos, Adrianos
Cinoku, Ilir
Mavragani, Clio P.
Moutsopoulos, Haralampos M.
CLINICAL IMMUNOLOGY, 2017, 183 : 300 - 303
[50] Hippocampal Atrophy Is Associated with Anti-NR2 Antibodies in Patients with Systemic Lupus Erythematosus and Primary Sjogren's Syndrome.
Lauvsnes, Maria B.
Beyer, Mona K.
Kvaloy, Jan T.
Greve, Ole J.
Appenzeller, Simone
Harboe, Erna
Tjensvoll, Anne B.
Goransson, Lasse G.
Omdal, Roald
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S513 - S514

← 1 2 3 4 5 →